MCT1/4 program (The Scripps Research Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMCT1/4 program (The Scripps Research Institute)
Drug Alias NameSR-11431 (The Scripps Research Institute/Moffitt Cancer Center and Research Institute)SR-11431
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonocarboxylate transporter 1 inhibitorsMonocarboxylate transporter 4 inhibitors
TargetsMonocarboxylate transporter 4Monocarboxylate transporter 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesH Lee Moffitt Cancer Center & Research InstituteThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A